Zymeworks Inc.
Nasdaq: ZYMEPharmaceutical Preparations · Entity-resolved by Clous
CIK0001937653
TickerZYME
ExchangeNasdaq
SIC2834
StateDE
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
RevenueFY2025-12-31
$105.97M
+38.9% YoY
Net IncomeFY2025-12-31
-$81.13M
+33.9% YoY
Total AssetsFY2025-12-31
$346.53M
-25.2% YoY
EquityFY2025-12-31
$268.5M
-20.7% YoY
Shares OutstandingFY2025-12-31
73.75M
—
Operating Cash FlowFY2025-12-31
-$33.01M
+70.0% YoY
Market
Market
ZYMEClose price
$23.16
Market cap
$1.69B
delayed EOD · as of 2026-06-18
Short interest & fails
Cost to borrow0.35%1.3M shares availablegeneral collateral
Short-sale volume
FINRA Reg SHO · daily44.5%
short of total volume · 2026-06-18
2026-06-1844.5%
2026-06-1739.0%
2026-06-1653.8%
2026-06-1557.1%
2026-06-1251.5%
Fails-to-deliver
SEC CNS fails · semi-monthly88
shares failed · 2026-05-26
2026-05-2688 sh$25.61
2026-05-20117 sh$24.40
2026-05-194.7K sh$24.43
2026-05-14309 sh$24.57
2026-05-0147 sh$27.54
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $412.48M | $76.01M | $76.3M | $105.97M | +38.9% | 100% |
| Net Income | $124.34M | -$118.67M | -$122.7M | -$81.13M | +33.9% | -77% |
| Total Assets | $648.73M | $580.88M | $463.09M | $346.53M | -25.2% | 327% |
| Equity | $492.96M | $464.81M | $338.77M | $268.5M | -20.7% | 253% |
| Operating Cash Flow | $144.11M | -$118.3M | -$110.04M | -$33.01M | +70.0% | -31% |
| Shares Outstanding | — | — | — | 73.75M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001937653